Aadi Bioscience downgraded to Neutral, shares fall (NASDAQ:AADI)
Aadi Bioscience (NASDAQ:AADI) was downgraded to Neutral from Overweight at Piper Sandler after it introduced that mid-stage examine of its stable tumors candidate…
THE HELITRA EDIT
Healthcare
Invivyd down 18% despite Pemgarda COVID risk reduction data
matejmo/E+ by way of Getty Images Patients handled with Invivyd’s (NASDAQ:IVVD) Pemgarda (pemivibart) confirmed an 84% relative risk reduction in symptomatic COVID-19 in…
Walgreens, Hims stocks drop as Lilly rolls out cheap weight-loss drugs (NASDAQ:WBA)
jetcityimage Walgreens Boots Alliance (NASDAQ:WBA) and Hims & Hers (NYSE:HIMS) stocks had been each down 7% in early afternoon buying and selling Tuesday…
Centene ending broker commissions for Medicare Part D (NYSE:CNC)
Alena Zharava/iStock by way of Getty Images Centene (NYSE:CNC) has determined to cease paying commissions to brokers and brokers who assist folks get…
Tonix stock jumps on collaboration for mpox vaccine candidate
Tonix stock jumps on collaboration for mpox vaccine candidate Source: Seekingalpha
PTC Therapeutics rises as UBS restarts coverage with buy rating
narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating.…
FDA sets target action date for Rhythm’s sNDA for Imcivree (NASDAQ:RYTM)
To guarantee this doesn’t occur sooner or later, please allow Javascript and cookies in your browser. Is this occurring to you often? Please…
Galapagos up 10% as major shareholder intends to talk about strategy
designer491 Galapagos (NASDAQ:GLPG) shares are up ~10% in Monday buying and selling after a big shareholder within the firm stated it believes the…
Evolent Health stock dips on report Elevance dropped out of bidding
Morsa Images/DigitalVision through Getty Images Evolent Health (NYSE:EVH) fell 4% amid a report that Elevance Health (ELV) is not bidding to accumulate the…
BofA starts Biohaven at purchase, cites “fast-follower” approach (NYSE:BHVN)
peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase ranking, citing its drug improvement applications for temper and autoimmune problems. The funding…
Cigna PBM Express Scripts to remove Humira from many formularies
JHVEPhoto/iStock Editorial by way of Getty Images AbbVie’s Humira (adalimumab) can be taken off the formulary lists of many Cigna (NYSE:CI) well being…
Merck snaps six straight sessions of gains
Erik S. Lesser/Getty Images News Merck (NYSE:MRK) shares snapped six straight sessions of gains, because the inventory closed 0.28% decrease at $116.27 on…